Dr. Kohichiro Tsuji

University of Tokyo, Japan

Email: [email protected]

Qualifications

1989 Ph.D., Medical Science, Shinshu University School of Medicine, Japan

1978 M.D., Shinshu University School of Medicine, Japan

Publications (Selected)

1. Shigemura, T., Matsuda, K., Kurata, T., et al. (2019). Essential role of PTPN11 mutation in enhanced haematopoietic differentiation potential of induced pluripotent stem cells of juvenile myelomonocytic leukaemia. British Journal of Haematology, 187(2), 163–173.
2. Nakata, Y., Ueda, T., Nagamachi, A., et al. (2017). Acquired expression of CblQ367P in mice induces dysplastic myelopoiesis mimicking chronic myelomonocytic leukemia. Blood, 129(15), 2148–2160.
3. Saito, S., Nishimura, S., Tsumura, M., et al. (2015). A comparison of myelopoiesis from induced pluripotent stem cells with a mutation in ELANE between cyclic neutropenia and severe congenital neutropenia. Blood, 126(23).
4. Yamamoto, S., Otsu, M., Matsuzaka, E., et al. (2015). Screening of drugs to treat 8p11 myeloproliferative syndrome using patient-derived induced pluripotent stem cells with fusion gene CEP110-FGFR1. PLOS ONE, 10(3), e0120841.
5. Sakashita, K., Kato, I., Daifu, T., et al. (2015). In vitro expansion of CD34+CD38- cells under stimulation with hematopoietic growth factors on AGM-S3 cells in juvenile myelomonocytic leukemia. Leukemia, 29(3), 606–614.
6. Sakurai, M., Kunimoto, H., Watanabe, N., et al. (2014). Impaired hematopoietic differentiation of RUNX1-mutated induced pluripotent stem cells derived from FPD/AML patients. Leukemia, 28(12), 2344–2354.
7. Singh, V. K., Saini, A., Tsuji, K., et al. (2014). Manufacturing blood ex vivo: A futuristic approach to deal with the supply and safety concerns. Frontiers in Cell and Developmental Biology, 2, 26.
8. Ebihara, Y., Ishikawa, K., Mochizuki, S., et al. (2014). Allogeneic stem cell transplantation for patients with acute myeloid leukaemia developing from severe congenital neutropenia. British Journal of Haematology, 164(3), 459–461.
9. Nagamachi, A., Nakata, Y., Ueda, T., et al. (2014). Acquired deficiency of A20 results in rapid apoptosis, systemic inflammation, and abnormal hematopoietic stem cell function. PLOS ONE, 9(1), e87425.
10. Yamamoto, S., Ebihara, Y., Mochizuki, S., et al. (2013). Quantitative polymerase chain reaction detection of CEP110-FGFR1 fusion gene in a patient with 8p11 myeloproliferative syndrome. Leukemia & Lymphoma, 54(9), 2068–2069.
11. Hiramoto, T., Ebihara, Y., Mizoguchi, Y., et al. (2013). The activation of the Wnt3a/β-Catenin pathway induced maturation of impaired neutrophils as well as the endoplasmic reticulum stress in induced pluripotent stem cell derived from a severe congenital neutropenia patient with ELANE mutation. Molecular Therapy, 21, S35–S35.
12. Hiramoto, T., Ebihara, Y., Mizoguchi, Y., et al. (2013). Wnt3a stimulates maturation of impaired neutrophils developed from severe congenital neutropenia patient-derived pluripotent stem cells. Proceedings of the National Academy of Sciences of the United States of America, 110(8), 3023–3028.
13. Sakurai, M., Kunimoto, H., Watanabe, N., et al. (2012). Impaired hematopoietic differentiation of iPSCs derived from patients with FPD/AML. Blood, 120(21).
14. Ebihara, Y., Ma, F., & Tsuji, K. (2012). Generation of red blood cells from human embryonic/induced pluripotent stem cells for blood transfusion. International Journal of Hematology, 95(6), 610–616.
15. Yamamoto, S., Ebihara, Y., Mochizuki, S., et al. (2012). Acute lymphoblastic leukemia with t(1;19)(q23;p13)/TCF3-PBX1 fusion in an adult male with Down syndrome. Acta Haematologica, 128(4), 242–243.
16. Hiramoto, T., Ebihara, Y., Mizoguchi, Y., et al. (2011). Suppressed neutrophil development in hematopoiesis of induced pluripotent stem cells derived from a severe congenital neutropenia patient with ELA2 mutation. Blood, 118(21), 331–331.

Profile Details
https://researchmap.jp/read0180873
https://www.researchgate.net/scientific-contributions/Kohichiro-Tsuji-39183215

WOS ResearcherID: ECZ-8101-2022